Abstract
Seventy-nine patients with cutaneous (62) or mucosal (17) infection with Leishmania (Viannia) braziliensis in Três Braços, Bahia, Brazil, were followed for at least 4 years after initiating treatment with antimony. Cutaneous relapses occurred in 6 62 (10%), mucosal relapse after cutaneous infection in 2 62 (3%), and mucosal relapse after mucosal disease in 2 17 (17%). It is concluded that relapse (cutaneous and mucosal) is rare after adequate antimony therapy and that no definite prediction of relapse (clinical, serological or by skin reaction) is possible.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have